MONDAY, Nov. 10, 2025 (Health News) — Millions of Americans who rely on medication for attention deficit hyperactivity disorder (ADHD) may be affected by a new drug recall.  Sun Pharmaceutical Industries has issued a voluntary, nationwide recall for several lots of lisdexamfetamine dimesylate capsules, a generic version of an ADHDContinue Reading

WEDNESDAY, Oct. 22, 2025 (HealthDay News) — The maker of Tylenol is urging U.S. health regulators not to add an autism warning label to it and other pain-relievers containing acetaminophen, calling the request “unsupported by the scientific evidence and legally and procedurally improper.” Kenvue’s response, dated Oct. 17, came afterContinue Reading